Peptomyc
PrivateLast Round
VC Round
Mar 24, 2024
Total Funding Raised
$24.69M
Company Overview
Peptomyc is a biotechnology company developing a new generation of cell-penetrating peptide therapeutics targeting the MYC oncogene for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptomyc Comps
Public and private peers based on sector, stage, and business model.
Peptomyc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Convertible Debt | Jan 20, 2022 | ||||
| VC Round | Dec 15, 2020 | ||||
| Series A | Sep 12, 2019 | ||||
Grant | Jul 30, 2019 |
Key People
Founding team and executive leadership
Peptomyc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon 2020 | Grant |
| European Innovation Council | Grant |
| European Innovation Council Fund | VC Round |
| Alta Life Sciences | VC Round, Convertible Debt, Series A |
| Healthequity SCR | VC Round, Series A, Convertible Debt, Seed |
| Agencia Estatal de Investigación | Debt |
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors grew 266% MoM to 3.1K.
- May 1, 2025
Monthly visitors grew 146% MoM, reaching 2.1K.
Peptomyc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peptomyc's valuation, stock price, and market status.
